<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="of these compounds using MTT assay on seven different human" exact="cancer" post="cell lines: HeLa, MDA-MB-231, A549, HepG2, U-87, SK-OV-3 and"/>
 <result pre="The studied extracts inhibited the cell proliferation of all tested" exact="cancer" post="cell lines with concentration dependent effect over time. All"/>
 <result pre="potent anticancer activity based upon marked induction of tumor-cell death." exact="cancer" post="Xylopia aethiopica Imperata cylindrical Echinops giganteus Dorstenia psilurus cell"/>
 <result pre="the adoption of behaviors and lifestyle factors known to cause" exact="cancer" post="[1]. Toxicity and tumor resistance are currently the main"/>
 <result pre="are currently the main limitations in using chemotherapeutic agents in" exact="cancer" post="treatment. So, the discovery of new and safe treatment"/>
 <result pre="used as heart and gastric troubles spice, reducing as well" exact="asthma" post="attacks. In previous studies, the root methanolic extract showed"/>
 <result pre="of EG roots also exhibited a significant activity against M." exact="tuberculosis" post="[19], the methanolic extract from the underground part also"/>
 <result pre="from the underground part also reported for cytotoxic activity against" exact="prostate cancer" post="(Mia PaCa2) and two leukemia cells (CCRF-CEM and CEM/ADR5000)"/>
 <result pre="the underground part also reported for cytotoxic activity against prostate" exact="cancer" post="(Mia PaCa2) and two leukemia cells (CCRF-CEM and CEM/ADR5000)"/>
 <result pre="for cytotoxic activity against prostate cancer (Mia PaCa2) and two" exact="leukemia" post="cells (CCRF-CEM and CEM/ADR5000) [20]. Dorstenia psilurus (DP), (family"/>
 <result pre="cytotoxic activity of these plant extracts against a variety of" exact="cancer" post="types and resistance. These studies have shown a promising"/>
 <result pre="shown a promising effect of using these extracts against some" exact="cancer" post="cell lines [25,26,27,28,29]. Despite the useful biological activity expressed"/>
 <result pre="in the inhibition of cell proliferation in seven different human" exact="cancer" post="cell lines: HeLa (cervical), MDA-MB-231 (breast), A549 (lung), HepG2"/>
 <result pre="any probable genetic toxicity upon using of these extracts in" exact="cancer" post="treatment. 2. Results and Discussion 2.1. Cell Proliferation Assay"/>
 <result pre="studied plant extracts was performed using MTT viability assay. Seven" exact="cancer" post="cell lines were incubated with the four extracts for"/>
 <result pre="confirmed that DP showed the most potent antitumor activity against" exact="cervical cancer" post="(HeLa) cancer after 72 h, among the four studied"/>
 <result pre="that DP showed the most potent antitumor activity against cervical" exact="cancer" post="(HeLa) cancer after 72 h, among the four studied"/>
 <result pre="showed the most potent antitumor activity against cervical cancer (HeLa)" exact="cancer" post="after 72 h, among the four studied extracts, with"/>
 <result pre="37.19 Âµg/mL. While IC expressed a higher cytotoxic activity against" exact="breast cancer" post="(MDA-MB-231) after 72 h with IC50 of 27.30 Âµg/mL."/>
 <result pre="Âµg/mL. While IC expressed a higher cytotoxic activity against breast" exact="cancer" post="(MDA-MB-231) after 72 h with IC50 of 27.30 Âµg/mL."/>
 <result pre="EG expressed the most potent activity in growth inhibition of" exact="leukemia" post="(HL60), while XA against glioblastoma brain cancer (U-87) with"/>
 <result pre="in growth inhibition of leukemia (HL60), while XA against glioblastoma" exact="brain cancer" post="(U-87) with IC50 of 41.05 and 35.45 Âµg/mL, respectively."/>
 <result pre="growth inhibition of leukemia (HL60), while XA against glioblastoma brain" exact="cancer" post="(U-87) with IC50 of 41.05 and 35.45 Âµg/mL, respectively."/>
 <result pre="(U-87) with IC50 of 41.05 and 35.45 Âµg/mL, respectively. In" exact="lung cancer" post="cells (A549), DP and XA were shown the most"/>
 <result pre="with IC50 of 41.05 and 35.45 Âµg/mL, respectively. In lung" exact="cancer" post="cells (A549), DP and XA were shown the most"/>
 <result pre="effect of the studied plant extracts after 48 h against" exact="ovarian cancer" post="(Sk-OV-3) cells was shown that DP and EG were"/>
 <result pre="of the studied plant extracts after 48 h against ovarian" exact="cancer" post="(Sk-OV-3) cells was shown that DP and EG were"/>
 <result pre="respectively. The four extracts have possessed closely antitumor activity against" exact="hepatocellular carcinoma" post="(HepG2) with a range from 32.99 to 53.21 Âµg/mL"/>
 <result pre="potential anticancer activity of these four extracts in these seven" exact="cancer" post="cell lines with concentration dependent effect over time. However,"/>
 <result pre="20 Âµg/mL after incubation 48 and 72 h treatment of" exact="cancer" post="cell lines [31]. Based on these results, the four"/>
 <result pre="evaluated by the ability to initiate cell cycle arrest in" exact="cancer" post="cells [32]. Production of apoptotic cells, which are resulting"/>
 <result pre="tumors that leads to increase in the mortality rate in" exact="cancer" post="disease [38]. In this study, wound-healing assay showed that"/>
 <result pre="h. These findings could represent potent anticancer agents that inhibited" exact="cancer" post="metastasis. 2.9. Single Cell Gel Electrophoresis Assay To assess"/>
 <result pre="The HEK293 cell line (human embryonic kidney) and the human" exact="cancer" post="cell lines: HeLa (cervical), MDA-MB-231 (breast), A549 (lung), HepG2"/>
 <result pre="These extracts could represent potential antitumor agents against the examined" exact="cancer" post="cells in a concentration dependent manner. Cell cycle analysis"/>
 <result pre="disruption. These extracts introduce a promising option for inhibition of" exact="cancer" post="cell metastasis. Further studies are warranted to identify the"/>
 <result pre="The authors declare no conflict of interest. References References 1.TorreL.A.BrayF.SiegelR.L.FerlayJ.Lortet-TieulentJ.JemalA.Global" exact="cancer" post="statistics, 2012CA Cancer J. Clin.2015658710810.3322/caac.2126225651787 2.AbdulaevF.I.Plant-derived agents against cancerPharmacology"/>
 <result pre="Prod.20066929029110.1021/np050380816499335 16.SawadogoW.R.SchumacherM.TeitenM.-H.DicatoM.DiederichM.Traditional West African pharmacopeia, plants and derived compounds for" exact="cancer" post="therapyBiochem. Pharm.2012841225124010.1016/j.bcp.2012.07.02122846603 17.FankamA.G.KueteV.VoukengI.K.KuiateJ.R.PagesJ.-M.Antibacterial activities of selected Cameroonian spices and"/>
 <result pre="Div.20127810.1186/1747-1028-7-822409878 26.AdaramoyeO.A.SarkarJ.SinghN.MeenaS.ChangkijaB.YadavP.P.SinhaS.Antiproliferative action of Xylopia aethiopica fruit extract on human" exact="cervical cancer" post="cellsPhytother. Res.2011251558156310.1002/ptr.355121698670 27.KeshavaR.MuniyappaN.GopeR.RamaswamaiahA.S.Anti-Cancer Effects of Imperata cylindrica Leaf Extract"/>
 <result pre="26.AdaramoyeO.A.SarkarJ.SinghN.MeenaS.ChangkijaB.YadavP.P.SinhaS.Antiproliferative action of Xylopia aethiopica fruit extract on human cervical" exact="cancer" post="cellsPhytother. Res.2011251558156310.1002/ptr.355121698670 27.KeshavaR.MuniyappaN.GopeR.RamaswamaiahA.S.Anti-Cancer Effects of Imperata cylindrica Leaf Extract"/>
 <result pre="mitochondrial dependent apoptosis and cell cycle arrest in human promyelocytic" exact="leukemia" post="HL-60 cells by an extract from Dorstenia psilurus: A"/>
 <result pre="TherapyOregon Medical PressPrinceton, MN, USA2001 32.DicksonM.A.SchwartzG.K.Development of cell-cycle inhibitors for" exact="cancer" post="therapyCurr. Oncol.200916364319370178 33.RiccardiC.NicolettiI.Analysis of apoptosis by propidium iodide staining"/>
 <result pre="generationInt. J. Biochem. Cell. Biol.20094166667610.1016/j.biocel.2008.07.01418718551 38.ChengG.Z.ChanJ.WangQ.ZhangW.SunC.D.WangL.H.Twist transcriptionally up-regulates AKT2 in" exact="breast cancer" post="cells leading to increased migration, invasion, and resistance to"/>
 <result pre="J. Biochem. Cell. Biol.20094166667610.1016/j.biocel.2008.07.01418718551 38.ChengG.Z.ChanJ.WangQ.ZhangW.SunC.D.WangL.H.Twist transcriptionally up-regulates AKT2 in breast" exact="cancer" post="cells leading to increased migration, invasion, and resistance to"/>
 <result pre="damaging effect of temoporfin (mTHPC) and merocyanine 540 (MC540) on" exact="nasopharyngeal carcinoma" post="cellToxicol. Lett.2000115536110.1016/S0378-4274(00)00174-010817631 40.AndersonD.YuT.W.PhillipsB.J.SchmezerP.The effect of various antioxidants and other"/>
 <result pre="Methods198365556310.1016/0022-1759(83)90303-46606682 43.SelvendiranK.TongL.VishwanathS.BrataszA.TriggN.J.KutalaV.K.HidegK.KuppusamyP.EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human" exact="ovarian cancer" post="cells by increasing PTEN expressionJ. Biol. Chem.2007282268092681810.1074/jbc.M703796200 44.AliM.Y.TariqI.AliS.AminM.U.EngelhardtK.PinnapireddyS.R.DuseL.SchÃ¤ferJ.SchÃ¤ferJ.Targeted ErbB3"/>
 <result pre="43.SelvendiranK.TongL.VishwanathS.BrataszA.TriggN.J.KutalaV.K.HidegK.KuppusamyP.EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian" exact="cancer" post="cells by increasing PTEN expressionJ. Biol. Chem.2007282268092681810.1074/jbc.M703796200 44.AliM.Y.TariqI.AliS.AminM.U.EngelhardtK.PinnapireddyS.R.DuseL.SchÃ¤ferJ.SchÃ¤ferJ.Targeted ErbB3"/>
 <result pre="cancer cells by increasing PTEN expressionJ. Biol. Chem.2007282268092681810.1074/jbc.M703796200 44.AliM.Y.TariqI.AliS.AminM.U.EngelhardtK.PinnapireddyS.R.DuseL.SchÃ¤ferJ.SchÃ¤ferJ.Targeted ErbB3" exact="cancer" post="therapy: A synergistic approach to effectively combat cancerInt. J."/>
</results>
